University | Diagnosis | Non-pharmacological treatment | Pharmacological treatment | |||
---|---|---|---|---|---|---|
n/N (%) | PR (95% CI)a | n/N (%) | PR (95% CI)a | n/N (%) | PR (95% CI)a | |
USMP | 33/113 (29.2) | 0.63 (0.46–0.86) | 39/118 (33.1) | 0.89 (0.66–1.19) | 16/118 (13.6) | 0.60 (0.36–0.99) |
UNMSM | 44/64 (68.8) | 1.88 (1.52–2.34) | 28/68 (41.2) | 1.17 (0.85–1.61) | 20/68 (29.4) | 1.61 (1.05–2.48) |
URP | 22/58 (37.9) | 0.90 (0.63–1.28) | 22/63 (34.9) | 0.96 (0.67–1.39) | 9/57 (15.8) | 0.76 (0.40–1.44) |
UCSur | 16/54 (29.6) | 0.68 (0.45–1.05) | 19/55 (34.5) | 0.95 (0.65–1.40) | 9/55 (16.4) | 0.79 (0.42–1.49) |
UPSJB | 22/47 (46.8) | 1.14 (0.82–1.59) | 15/44 (34.1) | 0.94 (0.61–1.45) | 11/45 (24.4) | 1.25 (0.72–2.18) |
UNFV | 14/38 (36.8) | 0.88 (0.57–1.35) | 13/40 (32.5) | 0.89 (0.56–1.42) | 7/39 (17.9) | 0.89 (0.44–1.79) |
UPCH | 15/23 (65.2) | 1.62 (1.18–2.24) | 12/23 (52.2) | 1.48 (0.98–2.24) | 9/24 (37.5) | 1.98 (1.13–3.44) |
UPC | 4/12 (33.3) | 0.80 (0.35–1.79) | 5/13 (38.5) | 1.07 (0.53–2.15) | 3/13 (23.1) | 1.16 (0.42–3.18) |